行情

TORC

TORC

resTORbio
NASDAQ

实时行情|Nasdaq Last Sale

9.68
-0.09
-0.92%
已收盘, 16:24 09/20 EDT
开盘
9.73
昨收
9.77
最高
9.92
最低
9.55
成交量
10.36万
成交额
--
52周最高
16.66
52周最低
6.21
市值
2.71亿
市盈率(TTM)
-6.9138
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TORC 新闻

  • 欧元区经济增长接近停滞 制造业重挫的影响开始蔓延
  • 新浪财经综合.32分钟前
  • 欧央行实现通胀目标之路 或事与愿违制造"减码恐慌"
  • 新浪财经综合.41分钟前
  • 3800点!这指标预示标普500指数有望突破历史高点?
  • 环球外汇网官网.41分钟前
  • 衰退担忧挥之不去 逢低买入美债仍是最佳选择?
  • 环球外汇网官网.44分钟前

更多

所属板块

制药
+1.04%
制药与医学研究
+0.95%

热门股票

名称
价格
涨跌幅

TORC 简况

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. It focuses on the mechanistic target of rapamycin (mTOR) pathway that regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1 (TORC1). Its initial focus is on the development of RTB101, an orally administered, small molecule, potent TORC1 inhibitor, alone and in combination with other mTOR inhibitors, such as everolimus. Its product pipeline includes the TORC1 program that includes the development of RTB101 for various indications. The indications include respiratory tract infections, heart failure with preserved ejection fraction, autophagy related neurodegenerative diseases and other indications. The Company is developing RTB101 in a Phase II b clinical trial.
展开

Webull提供resTORbio, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。